25-hydroxyprotopanaxadiol has been researched along with Invasiveness, Neoplasm in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, X; Fan, D; Hou, Y; Jiang, B; Liu, Y; Mou, T; Wang, P; Xia, X; Zhao, Y | 1 |
1 other study(ies) available for 25-hydroxyprotopanaxadiol and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Anti-tumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/β-catenin signaling inhibition.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; G1 Phase Cell Cycle Checkpoints; Ginsenosides; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasm Invasiveness; Panax; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2014 |